Literature DB >> 2855106

Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal blood.

L A Tannahill1, R C Dow, K M Fairhall, I C Robinson, G Fink.   

Abstract

The purpose of this study was to compare the control of adrenocorticotropin (ACTH) and corticosterone secretion in homozygous Brattleboro rats with their syngeneic controls, Long-Evans rats, and with rats of the Wistar strain. Plasma concentrations of ACTH and corticosterone were measured by radioimmunoassay in trunk blood, and corticotropin-releasing factor 41 (CRF-41), arginine vasopressin (AVP), and oxytocin were assayed in hypophysial portal vessel blood. Portal plasma was extracted with methanol for CRF-41 determination, and four different antisera and several different high-performance liquid chromatography (HPLC) systems were used to investigate AVP release. The peripheral plasma concentrations of ACTH and corticosterone were significantly higher in Long-Evans and homozygous Brattleboro than in Wistar rats. This difference was due, at least in part, to an approximately twofold greater release of CRF-41 into hypophysial portal blood of the Long-Evans and Brattleboro compared with Wistar rats. There was no significant difference between the strains in the output of oxytocin into portal blood. While no AVP could be detected in the neural lobe of homozygous Brattleboro rats, a small amount of AVP-like immunoreactivity was detected in unextracted hypophysial portal blood from homozygous Brattleboro rats. However, this AVP-like immunoreactivity was clearly distinct from authentic AVP in several HPLC systems, had no antidiuretic activity, and on gel filtration had a relative molecular mass greater than 5 kD. In contrast, the AVP-like immunoreactivity in hypophysial portal blood from Long-Evans rats co-eluted with authentic AVP in all HPLC systems tested.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2855106     DOI: 10.1159/000125077

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  6 in total

1.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.

Authors:  J P Liu; I J Clarke; J W Funder; D Engler
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

2.  Sucrose-induced plasticity in the basolateral amygdala in a 'comfort' feeding paradigm.

Authors:  Amy E B Packard; Shi Di; Ann E Egan; Sarah M Fourman; Jeffrey G Tasker; Yvonne M Ulrich-Lai
Journal:  Brain Struct Funct       Date:  2017-06-08       Impact factor: 3.270

3.  Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP).

Authors:  J Born; B Bathelt; R Pietrowsky; P Pauschinger; H L Fehm
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat.

Authors:  G W Bisset; H S Chowdrey; K M Fairhall; L K Gunn
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

5.  Sex-dependent effects of an early life treatment in rats that increases maternal care: vulnerability or resilience?

Authors:  Sílvia Fuentes; Núria Daviu; Humberto Gagliano; Pedro Garrido; Dóra Zelena; Nela Monasterio; Antonio Armario; Roser Nadal
Journal:  Front Behav Neurosci       Date:  2014-02-25       Impact factor: 3.558

6.  Male long-Evans rats: An outbred model of marked hypothalamic-pituitary-adrenal hyperactivity.

Authors:  Maria Sanchís-Ollé; Laura Sánchez-Benito; Silvia Fuentes; Humberto Gagliano; Xavier Belda; Patricia Molina; Javier Carrasco; Roser Nadal; Antonio Armario
Journal:  Neurobiol Stress       Date:  2021-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.